Growth Metrics

GeneDx Holdings (WGS) Net Income towards Common Stockholders: 2020-2025

Historic Net Income towards Common Stockholders for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to -$7.6 million.

  • GeneDx Holdings' Net Income towards Common Stockholders rose 8.14% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 102.50%. This contributed to the annual value of -$52.3 million for FY2024, which is 70.25% up from last year.
  • GeneDx Holdings' Net Income towards Common Stockholders amounted to -$7.6 million in Q3 2025, which was down 170.64% from $10.8 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Net Income towards Common Stockholders high stood at $32.7 million for Q3 2021, and its period low was -$308.7 million during Q4 2022.
  • In the last 3 years, GeneDx Holdings' Net Income towards Common Stockholders had a median value of -$20.2 million in 2024 and averaged -$21.0 million.
  • As far as peak fluctuations go, GeneDx Holdings' Net Income towards Common Stockholders soared by 157.81% in 2021, and later plummeted by 668.23% in 2022.
  • Over the past 5 years, GeneDx Holdings' Net Income towards Common Stockholders (Quarterly) stood at -$40.2 million in 2021, then crashed by 668.23% to -$308.7 million in 2022, then surged by 91.65% to -$25.8 million in 2023, then spiked by 121.10% to $5.4 million in 2024, then climbed by 8.14% to -$7.6 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$7.6 million for Q3 2025, versus $10.8 million for Q2 2025 and -$6.5 million for Q1 2025.